{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:22:11Z","timestamp":1788304931023,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T00:00:00Z","timestamp":1556841600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s12012-019-09524-x","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T22:03:54Z","timestamp":1556921034000},"page":"510-517","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Therapeutic Effects of Liraglutide, Oxytocin and Granulocyte Colony-Stimulating Factor in Doxorubicin-Induced Cardiomyopathy Model: An Experimental Animal Study"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4709-4222","authenticated-orcid":false,"given":"Emin","family":"Ta\u015fk\u0131ran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00fcmin Alper","family":"Erdo\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcrkan","family":"Yi\u011fitt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oytun","family":"Erba\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,3]]},"reference":[{"key":"9524_CR1","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","volume":"52","author":"Y Octavia","year":"2012","unstructured":"Octavia, Y., Tocchetti, C. G., Gabrielson, K. L., Janssens, S., Crijns, H. J., & Moens, A. L. (2012). Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies. Journal of Molecular and Cellular Cardiology,\n                           52, 1213\u20131225.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"9524_CR2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.pcad.2006.10.002","volume":"49","author":"G Takemura","year":"2007","unstructured":"Takemura, G., & Fujiwara, H. (2007). Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. Progress in Cardiovascular Diseases,\n                           49, 330\u2013352.","journal-title":"Progress in Cardiovascular Diseases"},{"key":"9524_CR3","doi-asserted-by":"publisher","first-page":"H1273","DOI":"10.1152\/ajpheart.00738.2005","volume":"291","author":"T L\u2019Ecuyer","year":"2006","unstructured":"L\u2019Ecuyer, T., Sanjeev, S., Thomas, R., Novak, R., Das, L., Campbell, W., et al. (2006). DNA damage is an early event in doxorubicin-induced cardiacmyocyte death. Am. J. Physiol Heart Circ. Physiol.,\n                           291, H1273\u2013H1280.","journal-title":"Am. J. Physiol Heart Circ. Physiol."},{"key":"9524_CR4","first-page":"410","volume":"12","author":"Y Wang","year":"2015","unstructured":"Wang, Y., & Yang, T. (2015). Liraglutide reduces oxidized DL induced oxidative stress and fatty degeneration in raw 264.7 cells involving the AMPK\/SREBP1 pathway. J of Geriatric Cardiology,\n                           12, 410\u2013416.","journal-title":"J of Geriatric Cardiology"},{"key":"9524_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/srep26859","author":"H Zhu","year":"2016","unstructured":"Zhu, H., Zhang, Y., Shi, Z., Lu, D., Li, T., Ding, Y., et al. (2016). The neuroprotection of liraglutide against ischemia-induced apoptosis through the activation of the PI3k\/Akt and MAP pathways. Scientific Reports. \n                    https:\/\/doi.org\/10.1038\/srep26859\n                    \n                  .","journal-title":"Scientific Reports"},{"key":"9524_CR6","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1016\/j.peptides.2006.03.029","volume":"27","author":"NK Biyikli","year":"2006","unstructured":"Biyikli, N. K., Tugtepe, H., Sener, G., Velioglu-Ogunc, A., Cetinel, S., & Midillioglu, S. (2006). Oxytocin alleviates oxidative renal injury in pyelonephritic rats via a neutrophil-dependent mechanism. Peptides,\n                           27, 2249\u20132257.","journal-title":"Peptides"},{"key":"9524_CR7","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.peptides.2012.05.026","volume":"38","author":"O Erbas","year":"2012","unstructured":"Erbas, O., Oltulu, F., & Taskiran, D. (2012). Amelioration of rotenone-induced dopaminergic cell death in the striatum by oxytocin treatment. Peptides,\n                           38, 312\u2013317. \n                    https:\/\/doi.org\/10.1016\/j.peptides.2012.05.026\n                    \n                  .","journal-title":"Peptides"},{"key":"9524_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.neulet.2010.10.012","volume":"487","author":"S Song","year":"2011","unstructured":"Song, S., Sava, V., Rowe, A., Li, K., Cao, C., Mori, T., et al. (2011). Granulocyte-colony stimulating factor (G-CSF) enhances recovery in mouse model of Parkinson\u2019s disease. Neuroscience Letters,\n                           487, 153\u2013157.","journal-title":"Neuroscience Letters"},{"key":"9524_CR9","first-page":"341","volume":"52","author":"Y Ha","year":"2005","unstructured":"Ha, Y., Park, H. S., Park, C. W., Yoon, S. H., Park, S. R., Hyun, D. K., et al. (2005). Granulocyte macrophage colony stimulating factor (GM-CSF) prevents apoptosis and improves functional outcome in experimental spinal cord contusion injury. Clinical Neurosurgery,\n                           52, 341\u2013347.","journal-title":"Clinical Neurosurgery"},{"key":"9524_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1034\/j.1600-0773.2003.930301.x","volume":"93","author":"KB Wallace","year":"2003","unstructured":"Wallace, K. B. (2003). Doxorubicin-induced cardiac mitochondrionopathy. Pharmacology and Toxicology,\n                           93, 105\u2013115.","journal-title":"Pharmacology and Toxicology"},{"key":"9524_CR11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0024-3205(00)00638-X","volume":"67","author":"C Demougeot","year":"2000","unstructured":"Demougeot, C., Marie, C., & Beley, A. (2000). Importance of iron location in iron-induced hydroxyl radical production by brain slices. Life Sciences,\n                           67, 399\u2013410.","journal-title":"Life Sciences"},{"key":"9524_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00441-012-1475-8","volume":"350","author":"P Dimitrakis","year":"2012","unstructured":"Dimitrakis, P., Romay-Ogando, M. I., Timolati, F., Suter, T. M., & Zuppinger, C. (2012). Effects of doxorubicin cancer therapy on autophagy and the ubiquitin-proteasome system in long-term cultured adult rat cardiomyocytes. Cell and Tissue Research,\n                           350, 361\u2013372.","journal-title":"Cell and Tissue Research"},{"key":"9524_CR13","doi-asserted-by":"publisher","first-page":"710","DOI":"10.7326\/0003-4819-91-5-710","volume":"91","author":"DD Von Hoff","year":"1979","unstructured":"Von Hoff, D. D., Layard, M. W., Basa, P., Davis, H. L., Jr., Von Hoff, A. L., Rozencweig, M., et al. (1979). Risk factors for doxorubicin-induced congestive heart failure. Annals of Internal Medicine,\n                           91, 710\u2013717.","journal-title":"Annals of Internal Medicine"},{"key":"9524_CR14","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1002\/cncr.11407","volume":"97","author":"SM Swain","year":"2003","unstructured":"Swain, S. M., Whaley, F. S., & Ewer, M. S. (2003). Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer,\n                           97, 2869\u20132879.","journal-title":"Cancer"},{"key":"9524_CR15","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2","volume":"32","author":"E Lefrak","year":"1973","unstructured":"Lefrak, E., Pit\u2019ha, J., Rosenheim, S., & Gottlieb, J. (1973). A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer,\n                           32, 302\u2013314.","journal-title":"Cancer"},{"key":"9524_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejcsup.2014.03.002","volume":"12","author":"BMP Aleman","year":"2014","unstructured":"Aleman, B. M. P., Moser, E. C., Nuver, J., Suter, T. M., Maraldo, M. V., Specht, L., et al. (2014). Cardiovascular disease after cancer therapy. European Journal of Cancer Supplements,\n                           12, 18\u201328.","journal-title":"European Journal of Cancer Supplements"},{"issue":"5","key":"9524_CR17","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1073\/pnas.1321783111","volume":"111","author":"B Aryal","year":"2014","unstructured":"Aryal, B., Jeong, J., & Rao, V. A. (2014). Doxorubicin-induced carbonylation and degradation of cardiac myosin binding protein C promote cardiotoxicity. Proceedings of the National Academy of Sciences of the USA,\n                           111(5), 2011\u20132016.","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"9524_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1155\/2012\/217037","volume":"2012","author":"P Sharma","year":"2012","unstructured":"Sharma, P., Jha, A. B., Dubey, R. S., & Pessarakli, M. (2012). Reactive oxygen species, oxidative damage, and antioxidative defense mechanism in plants under stressful conditions. Journal of Botany,\n                           2012, 26.","journal-title":"Journal of Botany"},{"key":"9524_CR19","doi-asserted-by":"publisher","first-page":"33585","DOI":"10.1074\/jbc.M003890200","volume":"275","author":"S Kotamraju","year":"2000","unstructured":"Kotamraju, S., Konorev, E. A., Joseph, J., & Kalyanaraman, B. (2000). Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen. Role of reactive oxygen and nitrogen species. Journal of Biological Chemistry,\n                           275, 33585\u201333592.","journal-title":"Journal of Biological Chemistry"},{"key":"9524_CR20","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1006\/jmcc.2002.2110","volume":"34","author":"S Wu","year":"2002","unstructured":"Wu, S., et al. (2002). Adriamycin-induced cardiomyocyte and endothelial cell apoptosis: In vitro and in vivo studies. Journal of Molecular and Cellular Cardiology,\n                           34, 1595\u20131607.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"9524_CR21","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1124\/jpet.108.146423","volume":"328","author":"J Niu","year":"2009","unstructured":"Niu, J., Azfer, A., Wang, K., Wang, X., & Kolattukudy, P. E. (2009). Cardiac-targeted expression of soluble fas attenuates doxorubicin-induced cardiotoxicity in mice. Journal of Pharmacology and Experimental Therapeutics,\n                           328, 740\u2013748. \n                    https:\/\/doi.org\/10.1124\/jpet.108.146423\n                    \n                  .","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"9524_CR22","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.peptides.2014.02.015","volume":"55","author":"A Akdemir","year":"2014","unstructured":"Akdemir, A., Erbas, O., Gode, F., Ergenoglu, M., Yeniel, O., Oltulu, F., et al. (2014). Protective effect of oxytocin on ovarian ischemia-reperfusion injury in rats. Peptides,\n                           55, 126\u2013130.","journal-title":"Peptides"},{"key":"9524_CR23","doi-asserted-by":"crossref","unstructured":"Akman, T., Akman, L., Erbas, O., Terek, M. C., Taskiran, D., & Ozsaran, A. The preventive effect of oxytocin to cisplatin-induced neurotoxicity: An experimental rat model. BioMed Research International, 2015, Article ID 167235","DOI":"10.1155\/2015\/167235"},{"issue":"1","key":"9524_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/01616412.2016.1249630","volume":"39","author":"O Erbas","year":"2017","unstructured":"Erbas, O., Ta\u015fk\u0131ran, D., Oltulu, F., Yava\u015fo\u011flu, A., Bora, S., Bilge, O., et al. (2017). Oxytocin provides protection against diabetic polyneuropathy in rats. Neurological Research,\n                           39(1), 45\u201353. \n                    https:\/\/doi.org\/10.1080\/01616412.2016.1249630\n                    \n                  .","journal-title":"Neurological Research"},{"key":"9524_CR25","first-page":"1661","volume":"33","author":"H Gao","year":"2013","unstructured":"Gao, H., Hu, L., Li, D., et al. (2013). Effects of glycagon like peptide-1 on liver oxidative stress, TNF\u03b1 and TGF-\u03b21 in rats with non-alcoholic fatty liver disease. Nan FangYi Ke DaXue Xue Bao,\n                           33, 1661\u20131664. (In Chinese).","journal-title":"Nan FangYi Ke DaXue Xue Bao"},{"key":"9524_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1074\/jbc.M209423200","volume":"278","author":"Y Li","year":"2003","unstructured":"Li, Y., Hansotia, T., Yusta, B., Ris, F., Halban, P. A., & Drucker, D. J. (2003). Glycagon-like peptide-1 receptor signaling modulates beta cell apoptosis. Journal of Biological Chemistry,\n                           278, 471\u2013478.","journal-title":"Journal of Biological Chemistry"},{"key":"9524_CR27","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s00210-017-1414-z","volume":"390","author":"ATN Abbas","year":"2017","unstructured":"Abbas, A. T. N., & Kabil, L. S. (2017). Liraglutide ameliorates cardiotoxicity induced by doxorubicin in rats through the Akt\/GSK-3\u03b2 signaling pathway. Naunyn-Schmiedeberg\u2019s Archives of Pharmacology,\n                           390, 1145\u20131153.","journal-title":"Naunyn-Schmiedeberg\u2019s Archives of Pharmacology"},{"key":"9524_CR28","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1161\/01.CIR.0000142616.07367.66","volume":"110","author":"WC Shyu","year":"2004","unstructured":"Shyu, W. C., Lin, S. Z., Yang, H. I., Tzeng, Y. S., Pang, C. Y., Yen, P. S., et al. (2004). Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells. Circulation,\n                           110, 1847\u20131854.","journal-title":"Circulation"},{"key":"9524_CR29","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1503\/cmaj.051322","volume":"174","author":"WC Shyu","year":"2006","unstructured":"Shyu, W. C., Lin, S. Z., Lee, C. C., Liu, D. D., & Li, H. (2006). Granulocyte colony-stimulating factor for acute ischemic stroke: A randomized controlled trial. CMAJ,\n                           174, 927\u2013933.","journal-title":"CMAJ"},{"key":"9524_CR30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/00062752-199805000-00013","volume":"5","author":"T Hartung","year":"1998","unstructured":"Hartung, T. (1998). Anti-inflammatory effects of granulocyte colony-stimulating factor. Current Opinion in Hematology,\n                           5, 221\u2013225.","journal-title":"Current Opinion in Hematology"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-019-09524-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12012-019-09524-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-019-09524-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T23:11:06Z","timestamp":1588374666000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12012-019-09524-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,3]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["9524"],"URL":"https:\/\/doi.org\/10.1007\/s12012-019-09524-x","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,3]]},"assertion":[{"value":"3 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors did not declare any conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}